WHO: New global youth competition on influenza and COVID-19 prevention and control
Submissions will open on Monday 3 August 2026, until Sunday 13 September 2026.
News
Scientific Papers
Reports
How benchmarking of bioinformatics tools is essential for informed workflow selection: a case study on SARS-CoV-2 sgRNA detection
New report from the Joint Research Centre (JRC)
Summary Report: IDC Stakeholder Community Meeting - 10 June 2026, Brussels
Key takeaways and next steps from the first in-person meeting of the IDC
Euronews: Trump administration pulls Covid-19 vaccine safety studies
The US FDA has halted the publication of a number of scientific studies confirming vaccine safety.
ESWI Activity Report for 2025
Intravenous immunoglobulin treatment for long COVID: a case report of clinical and immunological findings
Immunomodulation could represent a rational therapeutic approach to be evaluated in selected patients.
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients
In two open-label trials, nirmatrelvir–ritonavir did not reduce the incidence of hospitalization or death among vaccinated higher-risk participants with SARS-CoV-2 infection.
Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections
AAN-I-IFNs+ patients with life-threatening COVID-19 pneumonia harbor circulating type-I IFN-specific B cells indistinguishable from patients bearing T cell tolerance defects of genetic origin.